Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

The challenges of conducting clinical endpoint studies.

Isaacsohn JL, Khodadad TA, Soldano-Noble C, Vest JD.

Curr Atheroscler Rep. 2003 Jan;5(1):11-4. Review.

PMID:
12562536
[PubMed - indexed for MEDLINE]
2.

Design and analysis of clinical trials with a bivariate failure time endpoint, with application to AIDS Clinical Trials Group Study A5142.

DiRienzo AG, DeGruttola V.

Control Clin Trials. 2003 Apr;24(2):122-34.

PMID:
12689734
[PubMed - indexed for MEDLINE]
3.

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. Review.

PMID:
18477802
[PubMed - indexed for MEDLINE]
Free Article
4.

Some issues with composite endpoints in clinical trials.

Chi GY.

Fundam Clin Pharmacol. 2005 Dec;19(6):609-19. Review.

PMID:
16313272
[PubMed - indexed for MEDLINE]
5.

A consistency-adjusted alpha-adaptive strategy for sequential testing.

Alosh M, Huque MF.

Stat Med. 2010 Jul 10;29(15):1559-71. doi: 10.1002/sim.3896.

PMID:
20552571
[PubMed - indexed for MEDLINE]
6.

Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.

Moyé LA, Deswal A.

Control Clin Trials. 2001 Dec;22(6):605-19. Review.

PMID:
11738119
[PubMed - indexed for MEDLINE]
7.

Personal view: adequate relief as a primary endpoint in irritable bowel syndrome.

Mangel AW.

Aliment Pharmacol Ther. 2006 Apr 1;23(7):879-81. Review.

PMID:
16573790
[PubMed - indexed for MEDLINE]
Free Article
8.

Sample size estimates for atrial fibrillation endpoints.

Warman EN, Grammatico A, Padeletti L.

Heart Rhythm. 2004 Jul;1(2 Suppl):B58-62, discussion B63. Review.

PMID:
15851141
[PubMed - indexed for MEDLINE]
9.

Evaluating co-primary endpoints collectively in clinical trials.

Li QH.

Biom J. 2009 Feb;51(1):137-45. doi: 10.1002/bimj.200710497.

PMID:
19219905
[PubMed - indexed for MEDLINE]
10.

Analysis of a binary composite endpoint with missing data in components.

Quan H, Zhang D, Zhang J, Devlamynck L.

Stat Med. 2007 Nov 20;26(26):4703-18.

PMID:
17431851
[PubMed - indexed for MEDLINE]
11.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J.

Pain. 2008 Oct 31;139(3):485-93. doi: 10.1016/j.pain.2008.06.025. Epub 2008 Aug 15. Review.

PMID:
18706763
[PubMed - indexed for MEDLINE]
12.

How to deal with multiple endpoints in clinical trials.

Neuhäuser M.

Fundam Clin Pharmacol. 2006 Dec;20(6):515-23. Review.

PMID:
17109645
[PubMed - indexed for MEDLINE]
13.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

PMID:
16266559
[PubMed - indexed for MEDLINE]
Free Article
14.

On Two-stage Seamless Adaptive Design in Clinical Trials.

Chow SC, Tu YH.

J Formos Med Assoc. 2008 Dec;107(12 Suppl):52-60.

PMID:
19129046
[PubMed - indexed for MEDLINE]
15.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
16.

Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials.

Tao Y, Klause A, Vickers A, Bae K, Ellis M.

J Steroid Biochem Mol Biol. 2005 May;95(1-5):91-5.

PMID:
15994076
[PubMed - indexed for MEDLINE]
17.

Design of clinical trials of gene therapy in Parkinson disease.

Lewis TB, Standaert DG.

Exp Neurol. 2008 Jan;209(1):41-7. Epub 2007 Aug 31. Review.

PMID:
17920590
[PubMed - indexed for MEDLINE]
18.

Interim futility analysis with intermediate endpoints.

Goldman B, LeBlanc M, Crowley J.

Clin Trials. 2008;5(1):14-22. doi: 10.1177/1740774507086648.

PMID:
18283075
[PubMed - indexed for MEDLINE]
19.

A new and rapid scoring system to assess the scientific evidence from clinical trials.

Silber S.

J Interv Cardiol. 2006 Dec;19(6):485-92.

PMID:
17107362
[PubMed - indexed for MEDLINE]
20.

Partition testing in dose-response studies with multiple endpoints.

Liu Y, Hsu J, Ruberg S.

Pharm Stat. 2007 Jul-Sep;6(3):181-92.

PMID:
17654696
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk